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Oral Cancer (OC) is one of the most frequent cancer in Head and Neck district and 
Oral Squamous Cell Carcinoma (OSCC) constitutes the large majority of the neoplasia 
arising in oral cavity. OSCC remains a hampering matters for clinics, since the overall 
disease free survival has not significantly increased during the last decades and inva-
sion to surrounding tissue and to regional lymph nodes is often reported. Therefore 
new strategies to prevent and inhibit OSCC growth and invasion are highly desirable 
and new therapeutic approaches are currently tempted also with the use of natural 
compounds. Myricetin (MYR) and Naringenin (NAR), two naturally occurring flavo-
noids, widely diffused in plants, fruits and vegetable, have recently gained considera-
tion thanks to their anti oxidant, anti inflammatory and anti tumoral properties.
In this study their potential anticancer effect has been evaluated on an OSCC cell 
line, SCC-25 and on spontaneously immortalized non tumoral keratinocytes, HaCaT 
cells.
MYR and NAR induce a significant cell growth inhibition in SCC-25 cells, in 
addition NAR selectively affected cancer cells, since it does not impair HaCaT cell 
growth. Furthermore an additive effect of MYR and NAR has been highlighted. 
The cell proliferation inhibition is not related to apoptosis induction, as demon-
strated by evaluation of phosphatidyl serine membrane translocation and dapi stain-
ing. On the contrary MYR and NAR effect depends on the cell cycle progression 
impairment.
Wound-healing and cell invasion assays, respectively performed by cell monolay-
er scratch and Boyden Chamber transwell test, demonstrate that the two flavonoids 
are able to reduce motility and invasiveness on both SCC-25 and HaCaT cells. 
In conclusion the results of the present study show the anticancer potential of 
NAR and MYR on OSCC, since both flavonoids prevent cancer cell proliferation 
through a cytostatic effect, by the impairment of cell cycle progression. Moreover 
both the flavonoids inhibit cell migration, thus highlighting their potential effect as 
anti metastatic agents. 
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